The authors examined 95 randomized, controlled trials of antibiotic prophylaxis in afebrile neutropenic patients. Antibiotic
prophylaxis for neutropenic patients undergoing cytotoxic therapy reduced mortality, especially with fluoroquinolones. Physicians
should consider giving antibiotic prophylaxis, preferably with a fluoroquinolone, to neutropenic patients.